OrbusNeich has showcased its next-generation coronary balloon catheters at AsiaPCR/SingLIVE 2016 in Singapore. The Case-in-Point session, ‘Your complex PCI: How can new technologies enhance procedural success?’, reviewed solutions for calcified lesions with complex anatomy, where the dual-wire Scoreflex balloon can be used as an alternative to rotablation and featured chronic total occlusion (CTO) techniques with the Sapphire II PRO.
Aleksandra Milosevic (Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia) and others report in JACC: Cardiovascular Interventions that a strategy of immediate intervention in stabilised patients with non-ST-segment elevation myocardial infarction (NSTEMI) is associated with a significant reduction in new myocardial infarction at 30 days compared with a delayed intervention strategy.
An expert consensus statement has been released by the Society for Cardiovascular Angiography and Interventions (SCAI), intended to provide cardiologists, oncologists and internal medicine physicians with guidance for treating patients facing both cardiovascular disease and cancer.
Valentin Fuster, editor-in-chief of the Journal of the American College of Cardiology (JACC) has been awarded the Gran Cruz de la Orden Sanidad (Grand Cross of the Civil Order of Health) by the Spanish government. This is the highest Spanish civilian award granted in recognition of the achievement of an individual in the field of healthcare.
The Slender sirolimus-eluting coronary stent-on-a-wire integrated delivery system (IDS) (Svelte Medical Systems) is to be launched commercially to select European accounts, specialising in transradial intervention (TRI).
In a new scientific statement, published in Circulation, the American Heart Association (AHA) advises that the causes, symptoms, and outcomes of myocardial infarction may be different in women compared with men. It adds that these differences are further pronounced in Black and Hispanic women. The statement is the first scientific statement from the AHA on myocardial infarction in women.
Roxwood Medical has announced the expansion of its MicroCross catheter platform with the addition of the Micro14es (extra support) catheter. Micro14es is an extension of the Micro14 catheter, designed for complex peripheral and coronary disease.
RenalGuard Solutions has announced the STRENGTH trial, designed to evaluate the long-term clinical and economic impact of RenalGuard therapy in patients at high risk for contrast-induced acute kidney injury (CK-AKI), which will begin later this year.
Treatment by radial access is only used in a small number of high-risk heart attack patients who undergo rescue angioplasty, according to a study published in Journal of the American College of Cardiology: Cardiovascular Interventions. This is in spite of the fact that using the radial artery as the access point for angioplasty is associated with less bleeding than use of the femoral artery.
Scoring highly on the American Heart Association (AHA)’s Life’s Simple 7 checklist has been associated with a reduction in heart failure risk, according to a study published in the American Heart Association’s journal Circulation: Heart Failure.
A study published in JACC: Cardiovascular Interventions has shown that heart attack patients who have previously had coronary artery bypass graft surgery were less likely than other heart attack patients—including those with prior angioplasty—to be treated within the 90-minute recommended “door-to-balloon” time.
Patient delays have been associated with an increase in damage to the heart, according to a study published online in JACC: Cardiovascular Interventions.
The Lancet has published the largest meta-analysis conducted to date comparing different blood pressure targets. The authors recommend that blood pressure-lowering drugs should be offered to all people at a high risk of heart attack of stroke, regardless of their blood pressure at the start of treatment.
Research published in the European Journal of Preventative Cardiology has found that coronary heart disease patients who have lost all of their teeth have almost twice the risk of death than those with all of their teeth. The study found that, across 15,000 patients from 39 different countries, there was a linear association between levels of tooth loss and increasing death rates.
OrbusNeich has presented its new generation coronary balloon catheters at GulfPCR-GIM 2015 Cardiovascular Course in Dubai, UAE. A case-in-point session reviewed chronic total occlusion (CTO) techniques with the Sapphire II PRO, and discussed solutions for calcified lesions with complex anatomy where the dual wire Scoreflex balloon can be an alternative to rotablation.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos